STEAP1–4 (Six-Transmembrane Epithelial Antigen of the Prostate 1–4) and Their Clinical Implications for Prostate Cancer is a research paper published in Cancers (2022). On theSindex it has a DataRank of 0.601. It has been cited 54 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.601
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01CA224769
National Institutes of Health
Grant: 5R01CA224769-02
Integrin-mediated mechanisms of prostate cancer progression
FWCI
7.17
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family
Additional file 1 of A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family
Additional file 4 of A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family
Additional file 4 of A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family
Additional file 2 of A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family
Additional file 3 of A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family
Additional file 5 of A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family
Additional file 3 of A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family
Additional file 5 of A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family
Additional file 2 of A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family